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Abstract 
Background: Radiotherapy to the head and neck area damages the salivary glands. As a consequence hyposaliva-
tion may occur, but also the protein composition of saliva may be affected possibly compromising oral health. The 
aim of our study was to compare the relative abundance of proteins and peptides in parotid saliva of irradiated 
patients to that of healthy controls.
Methods: Using Lashley cups and citric acid, saliva from the parotid glands was collected from nine irradiated 
patients and ten healthy controls. The samples were analyzed with SELDI-TOF-MS using a NP20 and IMAC-30 chip in 
the molecular weight range of 1–30 kDa.
Results: On the NP20 chip 61 (out of 217) and on the IMAC-30 chip 32 (out of 218) peaks differed significantly in 
intensity between the saliva of the irradiated patients and healthy controls. 55 % of the significant peaks showed 
higher intensity and 45 % showed lower intensity in the saliva of irradiated patients. The peaks may represent, 
amongst others, the salivary proteins lysozyme, histatins, cystatin, protein S100 and PRP’s.
Conclusions: Large differences were found in the relative abundance of a wide range of proteins and peptides in the 
parotid saliva of irradiated patients compared to healthy controls.
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Background
Radiotherapy is often needed for the management of a 
tumor in the head and neck area. Usually radiotherapy 
involves the primary treatment of a tumor, but it can also 
be used additionally to surgery or as part of palliative 
care. The radiation-induced consequences for the healthy 
oral tissues can be divided into early and late effects. The 
early effects consist of damage to the oral mucosa, sali-
vary glands and taste. Late effects comprise damage to 
the salivary glands, dentition, periodontium, bone, mus-
cles and the joints [1, 2].
Damage to the salivary glands leads to a rapid decrease 
in salivary flow after the start of radiotherapy [3]. Weeks 
after the start of radiotherapy, the flow rate gradually 
starts to recover and only after 5 years the mean parotid 
flow rate may return to baseline levels [4, 5]. However, 
21 % of patients still suffered from a significantly lowered 
salivary flow 5 years after radiotherapy [5].
There are secondary effects related to changes in sali-
vary flow and to changes in composition. Saliva is an 
important host defense mechanism helping to keep the 
oral cavity free of diseases like caries, gingivitis, peri-
odontitis and infections as a result of antimicrobial, buff-
ering and remineralizing capacities [6, 7]. There is a risk 
for radiation caries, a form of caries that develops very 
rapidly when salivary functions are disturbed and affects 
tooth surfaces that are normally resistant to the develop-
ment of caries [8].
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Also the changes in the composition of saliva imply 
that the salivary pH and buffer capacity, as a result of a 
lower bicarbonate concentration, are significantly lower 
compared to healthy controls [9, 10] and the concentra-
tions of sodium, chloride, calcium, potassium, phosphate 
and magnesium in saliva have been changed [9–12]. The 
oral microflora also changes in composition. The increase 
of the acidogenic bacteria Streptococcus mutans and Lac-
tobacillus species and the yeast Candida may be a further 
threat for dental health [13–16].
After radiotherapy the total protein concentration may 
increase [9–11]. For individual proteins, it was found that 
the concentration of acidic proline-rich proteins (PRP’s), 
amylase, epidermal growth factor and MUC5B in the 
saliva of irradiated patients was lower than in healthy 
controls [9, 17–19], whereas the levels of lactoferrin, 
lysozyme, albumin, peroxidase, IgA, IgG and haptocor-
rin in saliva were elevated after irradiation [9–12, 18, 
20]. When interpreting the changed concentrations of 
salivary proteins, it should be taken into account that the 
amount of salivary flow determines the total availability 
of these proteins in the oral cavity [10, 21].
The salivary proteins studied in irradiated patients so 
far make up only a small proportion of the total amount 
of proteins and peptides in saliva [6, 22]. More knowl-
edge on the changes in a wide range of salivary proteins 
and peptides could make it possible to screen patients 
for specific markers for the prediction of oral health, to 
monitor effects of treatment or preventive measures and 
to follow the composition over time.
Surface enhanced laser desorption/ionization time-of-
flight mass spectrometry (SELDI-TOF-MS) is a method 
for the proteomic analysis of saliva [23]. It is a high 
throughput method that produces protein/peptide pro-
files of biological samples in the range of about 1–30 kDa 
[24, 25]. This technique separates proteins and peptides 
using their chemical and physical characteristics. Upon 
laser desorption and ionization an accurate protein/pep-
tide profile of the sample is generated. SELDI-TOF-MS 
was used in several clinical studies to discover biomark-
ers [26–30] in saliva and to examine proteomic profiles in 
the saliva of hematopoietic stem cell transplant patients 
[31].
Our hypothesis was that many more salivary proteins 
differ between irradiated patients and healthy controls 
than those that were studied before. We conducted a 
cross-sectional study in which we compared proteins and 
peptides in parotid saliva between healthy controls and 
patients that were irradiated in the head and neck area. 
The aim of our study was to make an inventory of the 
differences in the relative abundance of a wide range of 
proteins in the parotid saliva of irradiated patients and 
healthy controls using SELDI-TOF-MS.
Methods
Subjects
Nine patients (5 females, 4 males) who had received radi-
otherapy for a tumor in the head and neck area partici-
pated in this study. The mean age of the patients was 60.7 
(±11.9) years old. Radiotherapy took place over 6 months 
ago. In all patients the parotid glands were in the field of 
irradiation. The mean dosage of irradiation on the parotid 
glands was 29.3 (±11.5) Gy.
Ten healthy volunteers (7 males, 3 females) also par-
ticipated in this study. Their mean age was 39.8 (±12.2) 
years old. They had no known abnormalities in their sali-
vary glands and they did not use any medication affecting 
salivary flow.
The medical ethical committee of the NKI/AvL hospital 
was consulted about this study. The medical ethical com-
mittee determined that this study was exempt from eth-
ics approval since the study was about the non-invasive 
collection of a single sample in a small group of patients. 
All participants gave informed consent.
Saliva collection and storage
Saliva from the left and right parotid gland was col-
lected using Lashley cups. Salivary flow was stimulated 
by applying a 4 % citric acid solution to the lateral bor-
der of the tongue every 30 s. Saliva was collected during 
4  min. After collection a proteinase inhibitor cocktail 
(PIC; P8340, Sigma, St. Louis, MI, USA) was added to the 
samples. The samples were frozen immediately in liquid 
nitrogen and kept at −80 °C until analysis.
Saliva handling and analysis
The saliva samples were analyzed using SELDI-TOF-MS 
(Bio-Rad, Freemont, USA). Two ProteinChip surfaces 
were used: the IMAC-30 chip (binds proteins based on 
metal affinity) and the NP20 chip (general binding of pro-
teins). All chips were loaded according to the manufac-
turer’s instructions (Bio-Rad).
Saliva samples were thawed and centrifuged at 10,000g 
for 5 min. The supernatants were used for analysis. The 
NP20 chip preparation procedure started with washing 
of each spot with 5  µl PBS. The PBS was removed and 
5 µl of sample per spot was loaded. The chips were incu-
bated at room temperature for 20 min under gentle agita-
tion. The chips were washed twice with PBS and air-dried 
at room temperature for 15  min. Matrix sinapinic acid 
(50  % ACN, 0.5  % TFA) was applied twice (0.8  µl each 
time and 1 min apart). Finally, the chips were air-dried at 
room temperature.
The IMAC-30 chip preparation procedure started with 
loading of 50  µl of 0.1  M copper sulphate per spot for 
10  min. The spots were washed with 150  µl demineral-
ized water. Then the chip surface was neutralized using 
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150 µl 0.1 M sodium acetate buffer at pH 4.0 per spot for 
5 min. After washing with 150 µl demineralized water the 
spots were pre-incubated twice with 150  µl of binding 
buffer (0.1 M Tris–HCL, pH 7.4) for 5 min. 1 µl of sample 
and 99 µl of binding buffer per spot were incubated for 
1 h at room temperature under agitation. The spots were 
washed twice with 150 µl binding buffer for 5 min, once 
with demineralized water and air-dried. Matrix sinapinic 
acid (50  % ACN, 0.5  % TFA) was applied twice (0.8  µl 
each time and 1 min apart) and air-dried.
The externally calibrated chips were read on a Pro-
teinChip Reader IIC instrument (Bio-Rad). The follow-
ing settings were used: detector voltage 2500 V, acquired 
mass range from 1 to 30 kDa, focus mass 15 kDa, matrix 
attenuation was 1  kDa sampling rate at 400  MHz, 2 
warning shots were fired at each position, which were 
not included in the collection, 5 data shots were fired at 
2500 nJ.
Protein prediction
From SELDI-TOF-MS data it is not possible to exactly 
determine to which (part of ) specific proteins and pep-
tides the found peaks correspond as a result of a low 
mass resolution and a lack of tandem mass spectromet-
ric capabilities, which limits the identification of proteins 
and peptides [25].
The TagIdent tool (http://web.expasy.org/tagident/) 
was used to search for proteins that matched the signifi-
cant SELDI peaks using Swiss-Prot as the database, with 
human as the organism, with and without the keyword 
‘secreted’. Searches were carried out using the molecular 
weight data obtained from the SELDI-TOF-MS analysis 
with a 1 % molecular weight range.
Statistical analysis
Peak labeling and statistical analyses of the SELDI-
TOF-MS data were performed with ProteinChip Data 
Manager Software (version 3.0) for peaks with a signal-
to-noise ratio of ≥3.0 in the range from 1 to 30 kDa. Nor-
malization of the data did not influence overall results. 
Non-parametric Mann–Whitney tests were performed to 
compare protein profiles between groups. For the correc-
tion of multiple testing, the FDR method was used [32], 
with a critical value for the false discovery rate of 0.15 
and a total number of tests of 435. That corresponded to 
a p value <0.01. Other statistical analyses were carried 
out using the statistical software package SPSS version 
18.
Results
Figure 1 depicts a protein profile of two patients and two 
healthy controls generated by the IMAC-30 chip. This 
figure displays amongst others peaks with an m/z value of 
11,748 and 14,720. These peaks were present in all sam-
ples, but they were clearly higher in intensity in the saliva 
samples of the irradiated patients. Other peaks in this fig-
ure were present in all samples and do not differ signifi-
cantly in intensity between the irradiated patient group 
and the healthy controls.
On the NP20 chip in total 217 unique peaks were 
detected. 29 Peaks showed a significant higher intensity 
and 32 peaks showed a significant lower intensity in the 
saliva of the irradiated patients (Table 1). All significant 
peaks are shown in Additional file 1: S1.
On the IMAC-30 chip in total 218 peaks were detected. 
23 Peaks showed a significant higher intensity and 9 
peaks showed a significant lower intensity in the irradi-
ated patients (Table 2). All significant peaks are shown in 
Additional file 1: S1.
When comparing the saliva samples from the left and 
right parotid glands no significant differences were found 
in peak intensity, neither for the healthy controls, nor for 
the irradiated patients. The amount of irradiation that the 
patients received on their left and right parotid glands 
did not differ significantly (p = 0.866).
The m/z values of all the 93 significantly different peaks 
were entered in the TagIdent tool and the search resulted 
in 3528 unique human Swiss-Prot entries. These Swiss-
Prot entries were intersected with a list of 917 known 
salivary proteins and peptides with International Pro-
tein Index (IPI) identifiers (20). The IPI identifiers were 
mapped to Swiss-Prot using the ID-mapping tool of 
UniProtKB (http://www.uniprot.org). 143 IPI identi-
fiers could not be mapped. The intersection resulted in 
186 unique predicted proteins of which 65 are secreted, 
according to Swiss-Prot. Table 3 lists these 65 predicted 
proteins of which some have functions that are beneficial 
to oral health like lysozyme, histatins, proline rich pro-
teins (PRP’s) and S100 proteins.
Discussion
In this study, the rapid and high throughput SELDI-
TOF-MS technique was successfully used to show differ-
ences in proteins and peptides in the saliva of irradiated 
patients compared to healthy controls. The results are 
in agreement with our hypothesis; many more proteins 
were found to differ in intensity between the two groups 
than were studied previously. With this method, it is 
not only possible to compare protein profiles between 
groups, but also to rapidly screen patients for a specific 
protein marker related to (oral) disease and health, to 
observe the effects of a treatment or preventive measures 
and to follow composition in time.
Large differences in the composition of parotid saliva 
between irradiated patients and healthy controls were 
found: 93 peaks, measured by SELDI-TOF-MS, differed 
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significantly in intensity between both groups. Signifi-
cant peaks can correspond to known proteins and pep-
tides like lysozyme, histatins, PRP’s and S100 proteins. 
No differences were found in the protein composition of 
parotid saliva between the left and right parotid gland of 
both healthy controls and irradiated patients. This is in 
agreement with a previous study [25].
Until now, most studies were targeted at specific pro-
teins in the saliva between irradiated patients and healthy 
controls or before and after radiation treatment [9, 10, 
17, 33]. Differences were reported in lysozyme and PRP’s 
concentrations, predicted proteins that are found in our 
study as well [10, 17, 19]. The interesting point of our 
study is that we looked at a wide range of proteins and 
peptides identifying differences that were unnoticed until 
now. Some of the differences may comprise potential key 
proteins and peptides in determining oral health.
Other studies with SELDI-TOF-MS found significant 
differences in peaks between diseased and healthy per-
sons that correspond to our results [26, 28, 31]. Shintani 
et al. [26] identified a marker for oral squamous cell car-
cinoma that consisted of truncated cystatin SA. Ryu et al. 
[28] found several different peaks in Sjögren patients 
and identified two of the peaks as lysozyme C and cys-
tatin C. Imanguli et  al. [31] studied salivary changes in 
hematopoietic stem cell transplant patients. They found 
78 significantly different peaks comparing pre- and post 
transplant samples. One peak was identified as cysta-
tin SN. Future studies have to reveal whether various 
Fig. 1 SELDI-TOF-MS protein profiles of saliva samples. Protein profiles of saliva samples of two irradiated patients and two healthy controls 
obtained with the IMAC-30 chip
Table 1 Distribution of  peaks that  differed significantly 
in intensity on the NP20 chip






0–5000 27 6 21
5000–10,000 11 4 7
10,000–15,000 13 10 3
15,000–30,000 10 9 1
Total 61 29 32
Table 2 Distribution of  peaks that  differed significantly 
in intensity on the IMAC-30 chip






0–5000 7 2 5
5000–10,000 4 4 0
10,000–15,000 12 10 2
15,000–30,000 9 7 2
Total 32 23 9
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diseases and treatments bring about comparable changes 
in the salivary protein composition.
We searched for candidate proteins corresponding to 
the peaks with various protein databases. Among the 
proteins listed in Table 3 are proteins known to protect 
oral health, of others the importance is not clear yet. 
Lysozyme is an enzyme that kills bacteria by breaking 
down their cell wall. Cystatins are protease-inhibitors 
that contribute to the prevention of oral infections. The 
synthesis of cystatins is elevated, when the protective 
mechanisms in the mouth fail and oral infections origi-
nate [34]. Histatins are peptides with an antimicrobial 
function [35, 36]. Furthermore, histatins exhibit wound 
healing properties as well [37]. Calprotectin (protein 
S100A8 and A9) is a zinc- and calcium-binding protein 
that exhibits antimicrobial activity. It exhibits bacte-
riostatic properties and is an inflammatory marker in 
serum [38]. The levels of calprotectin in saliva are higher 
in the case of oral infections [39]. PRP’s are involved in 
the adherence of bacteria to the enamel pellicle [6]. This 
study indicates that oral health may be associated with 
changes in the whole salivary proteome, rather than only 
a few proteins, Therefore we need to study the whole sali-
vary proteome to find associations and possible mecha-
nisms between these proteins and oral health.
The mean age of the patients in our study was higher 
than of the healthy controls, due to one older patient. The 
changes in protein composition due to age are minimal 
and usually related to age-related medical conditions, as 
in our study [40]. In addition, by correcting the p value 
Table 3 Secreted proteins and  peptides that  resulted 
from the database search
UniProt accession Protein name
P31947 14-3-3 protein sigma
P01011 Alpha-1-antichymotrypsin
P03973 Antileukoproteinase
P04280 Basic salivary proline-rich protein 1
P10163 Basic salivary proline-rich protein 4
P61769 Beta-2-microglobulin









Q16610 Extracellular matrix protein 1
P08294 Extracellular superoxide dismutase [Cu–Zn]
P02751 Fibronectin






P01591 Immunoglobulin J chain
P15814 Immunoglobulin lambda-like polypeptide 1
Q14624 Inter-alpha-trypsin inhibitor heavy chain H4










O95467 Neuroendocrine secretory protein 55
P59665 Neutrophil defensin 1
P80188 Neutrophil gelatinase-associated lipocalin
O75594 Peptidoglycan recognition protein 1
P00747 Plasminogen








UniProt accession Protein name
P02753 Retinol-binding protein 4
P07998 Ribonuclease pancreatic
O00584 Ribonuclease T2
P02810 Salivary acidic proline-rich phosphoprotein 1/2
P36952 Serpin B5
Q99954 Submaxillary gland androgen-regulated protein 3A
P02814 Submaxillary gland androgen-regulated protein 3B
P10599 Thioredoxin
O60235 Transmembrane protease serine 11D
P07477 Trypsin-1
P35030 Trypsin-3
Q6MZM9 Uncharacterized protein C4orf40
P11684 Uteroglobin
P04004 Vitronectin
Q6PCB0 von Willebrand factor A domain-containing protein 1
Q14508 WAP four-disulfide core domain protein 2
Q96DA0 Zymogen granule protein 16 homolog B
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for multiple testing, we only found large differences in the 
relative abundance of proteins in parotid saliva. There-
fore, these differences have to be related to the impaired 
health condition and not to age differences.
The specific cause of the changes in protein compo-
sition that we found is not clear. It is possible that the 
disease itself altered the composition of saliva, but it 
can also be the (amount of ) irradiation that caused the 
changes. To distinguish between these possible options, 
it is necessary to compare the salivary protein composi-
tion of the cancer patients before and after radiotherapy.
In conclusion, many differences are found in the pro-
tein and peptide composition of parotid saliva of patients 
irradiated in the head and neck area compared to healthy 
controls. Of some proteins the relation with oral health 
is known, for others it remains to be established. It is 
important to look at a broad range of proteins to identify 
associations between changes in the salivary proteome 
and health or disease that were unnoticed until now. Fur-
ther research is needed to prospectively study changes 
in salivary proteins and to relate those changes to oral 
health.
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